The new facility will house its fast-growing CNC machining operations.
Industry
Up to 150 jobs in the regional nonprofit’s sales, technology and administrative services departments will be created in the process.
The speech was shorter and more personal than his previous addresses, and he used it to both look back at his time as governor and describe where he sees Minnesota going after he’s gone.
Four of the locations set to close are in Minnesota.
Latest Articles
Four of the locations set to close are in Minnesota.
The community bank’s shares finished at $12.85 Thursday after two days of public trading.
A report found that nurse recruitment and retention expenses will raise hospital operating costs.
The follow-on investment in Helix's $200 million Series B round furthers Mayo’s goal to ‘democratize’ patient knowledge.
A ‘dipstick’ test for urinary tract infections could one day be available in drugstores.
Allison O’Toole will move on to United States of Care as MNsure’s COO will replace her as acting CEO.
Portland developer Kevin Cavenaugh doesn't build a lot of traditional buildings. What he is known for -and what he came to Minneapolis to talk about - is building smaller.
Two investors who collectively own 60 percent of Cogentix Medical have already approved the deal's terms.
Less than two years after merging with St. Paul-based GovDelivery, leading government software solutions provider Granicus is expanding with a new acquisition.
The fast food chain said the relocation would improve efficiencies and allow it to upgrade technology and create a new test kitchen.
Local employers added 2,500 jobs in January, which didn't help much to boost Minnesota's job growth rate of 0.7 percent-currently less than half the national average of 1.5 percent.
A look at what local leaders think of the groundbreaking film, and the area’s own contributions to industry evolution.
That breaks with a decades-long trend that saw gun purchases increase after mass shootings.
The biopharmaceutical company plans to use the money to fund a new round of human trial testing.
The publicly traded Inovalon will be its new owner.